Cabrera-Jardines R, Alcaraz-Gutiérrez M, Ronzón-Fernández JB, Sánchez-Aguado ML, Moreno-Hernández MM

Language: Spanish
References: 7
Page: 531-534
PDF size: 397.90 Kb.

ABSTRACT

Background: The incidence of influenza B varies greatly each season.
Objective: To identify differences in the frequency of positive rapid tests for influenza B in the Hospital Angeles Pedregal (HAP) compared to Mexico and United States of America.
Material and method: A retrospective and epidemiological surveillance study was done with patients attending to Hospital Angeles Pedregal, Mexico City, in 2012, all of whom were submitted to rapid influenza test (QuickVue Influenza A + B test^®).
Results: Comparing the data of 22,030 RT-PCR tests reported for Mexico by the Pan American Health Organization vs 276,011 RT-PCR tests reported for United States by the Global Influenza Surveillance and Response System of the World Health Organization, we observed a statistically significant higher percentage of tests rapid positive to influenza B in the Hospital Angeles Pedregal regarding United States: 7.19 vs 3.31, p = 0.01.
Conclusion: Influenza B was more frequent in rapid testing of the population attending at Hospital Angeles Pedregal than in the RT-PCR tests in United States

REFERENCES

1. Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.

2. Bettis R, Iacuzio D, Jung T, Fuchs R, et al. Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents. Clin Drug Investig 2006;26:329-340.

3. http://www.paho.org/hq/index.php?option=com_content &view=article&id=3352&Itemid=2469&to=2246&lang=en

4. http://www.who.int/influenza/gisrs_laboratory/en/

5. Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus. J Mol Evol 2008;66:655-663.

6. Beran J, Wertzova V, Honegr K, Kaliskova E, et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis 2009;9:2

7. Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, et al. Clinical efficacy of cell culture-derived and eggderived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010;51:997-1004.